Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
207.94
+1.66 (0.80%)
Aug 7, 2026, 4:00 PM EDT - Market closed

Biogen Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
834.61,2931,6321,1622,9621,728
Depreciation & Amortization
842.9779.9673.2494.8518.4487.7
Stock-Based Compensation
296.3290.8291.2264.2254.1238.6
Other Adjustments
1,053898.6434.1275.4-1,4601,332
Change in Receivables
54.242.1194.256.7-222.4326
Changes in Inventories
155.1-64.7-273.8-130.9-320.2-462.4
Changes in Accrued Expenses
196.9171.124.6-201.6-113.4-95.4
Changes in Income Taxes Payable
-391.2-958.178.5-299-142.3230.8
Changes in Other Operating Activities
-315.5-248-178.7-73.9-92-144.5
Operating Cash Flow
2,8792,2052,8761,5471,3843,640
Operating Cash Flow Growth
36.00%-23.33%85.85%11.77%-61.97%-13.95%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-182.2-153.8-153.7-277-240.3-258.1
Sale of Property, Plant & Equipment
----582.693.5
Purchases of Intangible Assets
-206.6-81.6-206.1-34.4-2.9-36.8
Proceeds from Sale of Intangible Assets
--88.6---
Purchases of Investments
-2,155-1,258--5,141-3,449-3,809
Proceeds from Sale of Investments
2,22179.7551.58,2894,6613,405
Cash Acquisitions
---1,075-6,926--
Proceeds from Business Divestments
--406.8788.1990.328.1
Other Investing Activities
-112.3-7.183.9-11.324.4-5.1
Investing Cash Flow
-5,316-1,371-799.2-4,1011,577-563.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-0.31,733-997.2--
Long-Term Debt Repaid
--1,750-650-809.9-1,002-170
Net Long-Term Debt Issued (Repaid)
-0.3-16.9-650187.3-1,002-170
Repurchase of Common Stock
-----750-1,800
Net Common Stock Issued (Repurchased)
-----750-1,800
Other Financing Activities
-38-285-33.5-384.9-116.2
Financing Cash Flow
985-301.9-683.5149.3-1,747-2,086

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-22.1101.9-67.735.1-55.7-59.8
Net Cash Flow
-1,452531.61,393-2,4051,214990

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,6972,0512,7221,2701,1443,382
Free Cash Flow Growth
36.28%-24.65%114.28%11.03%-66.17%-11.12%
FCF Margin
26.89%20.73%28.13%12.91%11.24%30.79%
Free Cash Flow Per Share
18.2513.9418.668.727.8422.61
Levered Free Cash Flow
1,140802.41,152860.81,5701,316
Unlevered Free Cash Flow
1,3991,1012,120956.482,3082,464
SEC Filings: 10-K · 10-Q